Zobrazeno 1 - 10
of 15
pro vyhledávání: '"H. Bovio"'
Autor:
Hernán Cortés-Funes, Antonio Jimeno, Ramon Colomer, H Bovio, Cristina Grávalos, Isabel Sevilla, Pilar Escudero, Vicente Alonso, Rocio Garcia-Carbonero, M E Vega-Villegas, I Juez
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 10(1)
The objectives of this phase I/II study were to determine the maximum tolerated dose (MTD), characterise the principal toxicities in the phase I part and assess the efficacy in the phase II part of gefitinib, an oral selective inhibitor of the epider
Publikováno v:
Value in Health. 11(6):A493-A494
Autor:
H. Bovio, J.M. Vieitez, R. Cajal, M. Gonzalez-Baron, J. Nuevo, A. Jimenez-Lacave, J.R. Mel, P. Garcia-Alfonso, E. Alvarez
Publikováno v:
European Journal of Cancer Supplements. 1:S80-S81
Autor:
J. García-López, L. Gonzalez-de-Sande, A. Jimenez-Lacave, Margarita Reboredo, C Garcı́a-Girón, Jose María Vieitez, Manuel Valladares, Jesús García-Foncillas, H. Bovio, I. Pelaez
Publikováno v:
Journal of Clinical Oncology. 25:14523-14523
14523 Background: Second-line monotherapy activity in patients with metastatic CRC is low with an objective response rate of 9% in phase II-III studies (Viéitez et al, Am J Clin Oncol 2003; Rougier y cols., 1998). Gefitinib has shown activity in vit
Autor:
I. Rodriguez, Y. Escobar, A. Irigoyen, J. Valdivia, J. Nuevo, J. Belon, H. Bovio, P. Pastor, J. L. Alonso, A. Concha
Publikováno v:
Journal of Clinical Oncology. 23:5563-5563
5563 Background: Docetaxel and cisplatin (D/C) [75 mg/m2 each iv] combination therapy for squamous-cell carcinoma of the head and neck (SCCHN) yields response rates (RRs) of 30–40% and is relativel...
Autor:
G. Quintero, J. Feliu, A. Jimenez-Lacabe, H. Bovio, J.M. Vieitez, J. Nuevo, S. Vazquez, M.L. Garcia-deParedes, G. Perez-Manga
Publikováno v:
European Journal of Cancer Supplements. 1:S90
Autor:
J. Gibert, Fernando Rico-Villademoros, S. Herranz, H. Bovio, J. Jimenez, José Giner, A. Perez, C. Ovejero
Publikováno v:
European Neuropsychopharmacology. 12:270
Publikováno v:
European Neuropsychopharmacology. 12:272
Switching to quetiapine in schizophrenic patients with antipsychotic-induced extrapyramidal symptoms
Publikováno v:
European Neuropsychopharmacology. 12:267
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.